Eric Loh joined The Trendlines Group in 2016 and is responsible for the leadership and overall management of Trendlines Medical Singapore.
Eric brings more than 25 years of experience in the medical device industry to Trendlines. Previously, he had a significant role in developing Biosensors International, building this early-stage cardiovascular device company into a successful, publicly traded company on the Singapore Stock Exchange. As Managing Director, he oversaw the establishment of a joint venture operation in China that resulted in Biosensors’ successful entry into the fast- growing Chinese market.
He led successful sales and marketing efforts, and commercialized Biosensors’ products in other Asia Pacific markets while managing two manufacturing facilities in Singapore. In 2005, Eric was involved with the company’s IPO on the Singapore Stock Exchange.
After leaving Biosensors, Eric was the CEO of start-up EPI Mobile Health, where he achieved regulatory clearance from the FDA, CE, and HSA of a novel mobile ECG device that enabled the commercialization of the products in key markets in Asia.
Eric holds an MSc in medical engineering and a BEng (Hons), both from the National University of Singapore and is a graduate of an Executive MBA program affiliated with the Helsinki School of Economics. He is a CFA charter holder and is an Associate Chartered Valuer and Appraiser.